Sansert

Active Ingredient(s): Methysergide
FDA Approved: * February 12, 1962
Pharm Company: * NOVARTIS
Category: Migraine / Tension Headache

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Sansert Overview

Methysergide (1-methyl-D-lysergic acid butanolamide or UML-491) also known as methysergide maleate, is an ergot derived prescription drug used for the prophylaxis of difficult to treat migraine and cluster headaches. Methysergide is no longer recommended as a first line treatment protocol by international headache societies, hospitals, and neurologists in private practice, for migraines or cluster headaches as side effects were first reported with long-term use in the late 1960s, and ergot ba...

Read more Sansert Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Methysergide

Recent Sansert Forums: RSS Feed

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Methysergide
  • Tablet: 2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sansert: (1 result)

Sorted by National Drug Code
  • 0078-0058 Sansert 2 mg Oral Tablet by Novartis Pharmaceuticals Corporation

Other drugs which contain Methysergide or a similar ingredient: (1 result)

Related Sansert Topics:

Hope for getting Deseril/Sansert back?
I have been taking Sansert, later called Deseril in the U.K., and had almost none of the chronic daily migraines I had b... 1 reply




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA